SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-24-019240
Filing Date
2024-06-25
Accepted
2024-06-25 17:20:49
Documents
1
Period of Report
2024-06-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 2810
  Complete submission text file 0001127602-24-019240.txt   4565
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Issuer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CELL GENESYS, INC. 500 FORBES BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
SHERWIN STEPHEN A (Reporting) CIK: 0001079462 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 000-19311 | Film No.: 241069957